Lantheus Medical Imaging Chooses TrialStat as its Electronic Data Capture EDC Vendor for PostMarket Surveillance Study

TrialStat Corporation, the industry's first clinical data solutions on demand company, today added Lantheus Medical Imaging (LMI) (formerly Bristol Myers-Squibb Medical Imaging) to the company's growing list of ClinicalAnalytics 4.0 (CA 4.0) customers. LMI chose CA 4.0, TrialStat's on demand electronic data capture (EDC) solution, over other EDC vendors for its Web-based accessibility, versatility and ease-of-use.

CA 4.0 enables clinical research organizations to deploy EDC twice as quickly as the industry average, accelerating their clinical research process. LMI's U.S.-based 30 site, 1,600 patient post-market surveillance study will take place over an eighteen month period in 2008. Flexibility was key to LMI's decision to select TrialStat. Using CA 4.0, LMI can quickly change forms for protocol amendments, as well as simply change workflows to accommodate new research groups. In addition, LMI can readily adapt the configurable EDC platform for different clinical research phases, as it extends the use of CA 4.0 for other trials.

"We completed a thorough review of EDC vendors and chose TrialStat for its capacity to deliver a Web-accessible solution quickly," Gajanan Bhat, PhD, Director of Biostatistics and Data Management, Lantheus Medical Imaging. "TrialStat demonstrated that CA 4.0 was easy-to-use for research professionals with different levels of technology sophistication and regional adoption rates of IT infrastructure. Our ability to quickly deploy EDC to sites via CA 4.0's browser interface allows us to focus on study results rather than on technology. As well, and very early on, TrialStat impressed us with their responsive customer service and attention to detail, which, along with advanced product features, proved to be a winning combination."

"Partnering with Lantheus further underscores the industry's need for a fully-featured on demand EDC solution that is fast to deploy, versatile and easy to use," said Jonathan Barker, President and CEO, TrialStat. "Clinical research organizations now not only evaluate EDC on its features, but also on its usability and configurability for the many unique research environments of the life sciences industry."

ABOUT TRIALSTAT

TrialStat Corporation provides innovative clinical data solutions on demand that optimize the collection and management of research to enable customers to accelerate the commercialization of new life science products. CA 4.0 is a robust and scalable Web-based EDC on demand platform used by leading biopharma organizations. SRS 4.0 automates systematic reviews using real-time collaboration and management tools, while ESRNexus (www.esrnexus.com) is the most comprehensive and free Web-based search engine for evidence-based reference literature. More information about TrialStat is available at www.trialstat.com.

ABOUT LANTHEUS MEDICAL IMAGING

Lantheus Medical Imaging is a worldwide leader in medical imaging, with headquarters in North Billerica, Massachusetts, and nearly 700 employees worldwide with offices in Puerto Rico, Canada, and Australia. For more than half a century, the company has provided important products--including Cardiolite (Kit for the Preparation of Technetium Tc99m Sestamibi for Injection), DEFINITY Vial for (Perflutren Lipid Microsphere) Injectable Suspension and TechneLite (Technetium Tc99m Generator)--that illuminate the heart and other organs. Lantheus Medical Imaging will build on the solid foundation created by those products as it seeks out new ways of "bringing light" to the diagnosis and management of disease. For more information, visit www.lantheus.com.

ClinicalAnalytics 4.0, SRS 4.0 and ESRNexus are registered trademarks of TrialStat Corporation.

For media inquiries, please contact:

Muay Lim

TrialStat Corporation

613-741-9909 ext 153

mlim(at)trialstat.com




Lantheus Medical Imaging Chooses TrialStat as its Electronic Data Capture EDC Vendor for PostMarket Surveillance Study



***Note This page is an Archieve of Publicly released information either through our company or another Press Release organization. We do not "fact check", "Support", nor "Dispute" any of the information provided to us. We are a distribution point and Historical press release research and search service. This information only represents the fact that at one point in time the release was distributed to 1000's of publications both online and off. PRNewsNow will not take sides in any personal or commercial disputes you have with the writer of this press release. We will defend its right to exist blindly and without regards to its political, commercial or personal implications.***